Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home News

House unanimously approves barring anyone tied to Hamas’ Oct 7 attack from entering US

admin by admin
December 2, 2025
in News
0
House unanimously approves barring anyone tied to Hamas’ Oct 7 attack from entering US
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The House unanimously passed a bill on Monday barring anyone linked to Hamas’ Oct. 7, 2023 attack on Israel from moving to the United States.

It’s a rare moment of bipartisanship on the topic of Israel, an issue that’s otherwise exacerbated deep fractures within both parties in the House of Representatives — particularly for Democrats.

The Republican-led legislation is called the ‘No Immigration Benefits for Hamas Terrorists Act of 2025’ and was introduced by Rep. Tom McClintock, R-Calif.

It passed the House by voice vote on Monday afternoon, meaning it advanced with unanimous approval without lawmakers taking individual votes on the bill.

‘There are still some things we can come together on in this body, and one of them is opposition to Hamas and the terrorism they unleashed on civilians in Israel more than two years ago,’ McClintock told Fox News Digital.

‘What this does is place them in the same category as Nazi collaborators in the Holocaust, which are also referenced in the Immigration Nationality Act.’

The bill now heads to the U.S. Senate, where a parallel effort was introduced earlier this year by Sens. Marsha Blackburn, R-Tenn., and Jacky Rosen, D-Nev.

McClintock told Fox News Digital he was hopeful the Senate would take up the bill — while noting it passed the House last term as well without the upper chamber taking action.

‘The repeated actions of the House in passing this bill, I think, will hopefully inspire the Senate to take it up this year and send it to the president,’ he said. ‘It’s important for two reasons. Number one, to prevent a future Joe Biden from admitting such people, and to empower a future Donald Trump presidency to keep them out.’

The legislation would amend existing U.S. immigration law to deem ‘any alien who carried out, participated in, planned, financed, afforded material support to, or otherwise facilitated any of the attacks against Israel initiated by Hamas beginning on October 7, 2023’ inadmissible to the country.

It would also add Hamas and Palestinian Islamic Jihad to the list of terror groups whose members and supporters are barred from the U.S. under the Immigration and Nationality Act.

It comes after a Gazan native, Mahmoud Amin Ya’qub Al-Muhtadi, who was residing in Louisiana, was arrested earlier this year over his alleged involvement in the Oct. 7 attack.

This post appeared first on FOX NEWS

Previous Post

Spec ops chief ordered deadly Caribbean strike ‘in self-defense’ with Hegseth’s sign-off, White House says

Next Post

AI in finance: how machine learning is transforming trading

Next Post
AI in finance: how machine learning is transforming trading

AI in finance: how machine learning is transforming trading

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

February 19, 2025
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

0
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

December 24, 2025
GLP-1 weight-loss pills set to reshape US food demand in 2026

GLP-1 weight-loss pills set to reshape US food demand in 2026

December 24, 2025
US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

December 24, 2025
Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

December 24, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    December 24, 2025
    GLP-1 weight-loss pills set to reshape US food demand in 2026

    GLP-1 weight-loss pills set to reshape US food demand in 2026

    December 24, 2025
    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    December 24, 2025
    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    December 24, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved